Rothschild & Co Asset Management US’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Rothschild & Co Asset Management US's HALO Position: Q4 2022 in Review
Rothschild & Co Asset Management US reduced its Halozyme (HALO) stake by 3.4% in Q4 2022, selling an estimated $317K and leaving 176,487 shares worth $10M. The position accounts for 0.15% of the portfolio, ranked #103.
Rothschild & Co Asset Management US first reported a position in HALO in Q4 2021 and has held it in 5 quarters since. 423 funds tracked by Wall St. Rank hold HALO as of Q4 2022.
- Rothschild & Co Asset Management US held 176,487 shares of Halozyme worth $10M as of Q4 2022.
- Rothschild & Co Asset Management US sold 6,196 Halozyme shares in Q4 2022, an estimated $317K.
- Halozyme made up 0.15% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #103 holding.
- Rothschild & Co Asset Management US first reported a position in Halozyme in Q4 2021 and has held it in 5 quarters since.
- 423 funds tracked by Wall St. Rank held Halozyme as of Q4 2022.
Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.